According to the latest financial report of Co-diagnostics, the latest earnings per share (TTM) for the company is -0.32. Investing in companies with strong earnings per share can potentially provide higher returns.
Interested in knowing about Co-diagnostics's free cash flow? The latest report shows it as -7.40M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Co-diagnostics shows that the company's current ratio is 6.92, indicating healthy liquidity.
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Co-diagnostics, the quick ratio is 6.53, indicating that the company can meet its short-term debt obligations.
Want to learn more about the financial health of Co-diagnostics? The latest ROE figure is -14.24%, indicating that the company has stable profitability.
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Co-diagnostics, the total asset return on investment (ROA) is -12.67%.
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Co-diagnostics's latest financial report to see how their gross margin is doing - currently at 53.61%.
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Co-diagnostics, the net profit margin is -1.51K%, which is a good sign for its profitability.